Sign in

NCT03718364Recruiting

Swiss Atrial Fibrillation Pulmonary Vein Isolation Registry

Source: ClinicalTrials.gov · Last updated 18 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Registry of patients with atrial fibrillation undergoing catheter-based ablation of atrial fibrillation (pulmonary vein isolation) to determine long-term success rates of catheter-based ablation of atrial fibrillation (pulmonary vein isolation) and to evaluate factors associated with long-term success of catheter-based ablation of atrial fibrillation (pulmonary vein isolation).

Status (registry)
Recruiting
Study type
Observational
Enrollment
3000 (estimated)
First submitted
23 Oct 2018
Start date
1 Jul 2010
Primary completion date
Dec 2035
Lead sponsor
University Hospital, Basel, Switzerland
NCT number
NCT03718364

What you commit to

  • Study type: Observational
  • Planned participants: 3000
  • From 1 Jul 2010 to the primary completion date, Dec 2035
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Patients not able or willing to participate in this study

Who the study is looking for

  • patients undergoing catheter-based ablation of atrial fibrillation (pulmonary vein isolation)

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Cardiology/Electrophysiology, University Hospital Basel
Coordinator of this site? Confirm its status
BaselSwitzerlandRecruiting
University Hospital Bern
Coordinator of this site? Confirm its status
BernSwitzerlandRecruiting

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.